These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1369994

  • 21. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL, Guo YJ, Wang KY, Lu K, Li K, Zhu Y, Sun SH.
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [Abstract] [Full Text] [Related]

  • 22. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
    Kit M, Kit S, Little SP, Di Marchi RD, Gale C.
    Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
    [Abstract] [Full Text] [Related]

  • 23. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
    Sominskaya I, Skrastina D, Dislers A, Vasiljev D, Mihailova M, Ose V, Dreilina D, Pumpens P.
    Clin Vaccine Immunol; 2010 Jun; 17(6):1027-33. PubMed ID: 20410327
    [Abstract] [Full Text] [Related]

  • 24. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope.
    Lachmann S, Meisel H, Muselmann C, Koletzki D, Gelderblom HR, Borisova G, Krüger DH, Pumpens P, Ulrich R.
    Intervirology; 1999 Jun; 42(1):51-6. PubMed ID: 10393504
    [Abstract] [Full Text] [Related]

  • 25. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB, Ilyichev AA, Eroshkin AM, Karpenko LI, Pokrovsky AG, Pereboev AV, Svyatchenko VA, Ignat'ev GM, Smolina MI, Melamed NV, Lebedeva CD, Sandakhchiev LS.
    J Biotechnol; 1996 Jan 26; 44(1-3):129-37. PubMed ID: 8717396
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity of peptide fusions to hepatitis B virus core antigen.
    Stahl SJ, Murray K.
    Proc Natl Acad Sci U S A; 1989 Aug 26; 86(16):6283-7. PubMed ID: 2474830
    [Abstract] [Full Text] [Related]

  • 27. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B, Liu X, Zhou P, Fang Y, Zhao D, Zhang Y, Wang Y.
    Appl Microbiol Biotechnol; 2019 Apr 26; 103(8):3367-3379. PubMed ID: 30888465
    [Abstract] [Full Text] [Related]

  • 28. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A, Frömmel C, Sasnauskas K, Micheel B, Ozel M, Behrsing O, Staniulis J, Jandrig B, Scherneck S, Ulrich R.
    Virology; 2000 Jul 20; 273(1):21-35. PubMed ID: 10891404
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR, Garcia-Briones M, Periolo O, la Torre JL, Wagner RR.
    J Virol; 1996 Dec 20; 70(12):8492-501. PubMed ID: 8970972
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
    Ulrich R, Borisova GP, Gren E, Berzin I, Pumpen P, Eckert R, Ose V, Siakkou H, Gren EJ, von Baehr R.
    Arch Virol; 1992 Dec 20; 126(1-4):321-8. PubMed ID: 1381912
    [Abstract] [Full Text] [Related]

  • 31. Construction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.
    Guo YH, Hao ZM, Luo JY, Wang JH.
    World J Gastroenterol; 2005 Oct 28; 11(40):6389-94. PubMed ID: 16419171
    [Abstract] [Full Text] [Related]

  • 32. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q, Yang YQ, Zhang ZY, Li L, Yan WY, Jiang WJ, Xin AG, Lei CX, Zheng ZX.
    Acta Virol; 2002 Oct 28; 46(1):1-9. PubMed ID: 12199204
    [Abstract] [Full Text] [Related]

  • 33. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B.
    Biochemistry (Mosc); 1998 May 28; 63(5):551-8. PubMed ID: 9632891
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B virus core particles as epitope carriers.
    Pumpens P, Borisova GP, Crowther RA, Grens E.
    Intervirology; 1995 May 28; 38(1-2):63-74. PubMed ID: 8666525
    [Abstract] [Full Text] [Related]

  • 35. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium.
    Wu L, Diao Z, Deng X, Gao J, Zhou Z, Liu Y, Wang Y.
    J Nanosci Nanotechnol; 2005 Aug 28; 5(8):1204-10. PubMed ID: 16193978
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.
    Fuller DH, Shipley T, Allen TM, Fuller JT, Wu MS, Horton H, Wilson N, Widera G, Watkins DI.
    Virology; 2007 Aug 01; 364(2):245-55. PubMed ID: 17428516
    [Abstract] [Full Text] [Related]

  • 37. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F, Kelly SM, Peterson D, Milich D, Hughes J, Tinge S, Wirtz R, Curtiss R.
    Dev Biol Stand; 1994 Aug 01; 82():151-8. PubMed ID: 7958469
    [Abstract] [Full Text] [Related]

  • 38. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y, Song S, Liu C, Wang Y, Xian X, He Y, Wang J, Liu F, Sun S.
    Cell Immunol; 2007 May 01; 247(1):18-27. PubMed ID: 17707782
    [Abstract] [Full Text] [Related]

  • 39. [Hepatitis B virus core protein as an epitope vaccine carrier: a review].
    Yin Y, Xu J, Chen W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr 01; 26(4):431-8. PubMed ID: 20575429
    [Abstract] [Full Text] [Related]

  • 40. Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments.
    Koletzki D, Zankl A, Gelderblom HR, Meisel H, Dislers A, Borisova G, Pumpens P, Krüger DH, Ulrich R.
    J Gen Virol; 1997 Aug 01; 78 ( Pt 8)():2049-53. PubMed ID: 9267006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.